Void, not voidable
The word choice is the whole story. A void transfer never legally happened — it is not "challengeable in court" or "subject to review." The buyer is not recognized as a shareholder and has no rights. That is Anthropic's language, and OpenAI's statement from the same week is nearly identical: any transfer without written consent "will not be recognized and carry no economic value to you."
That matters most for SPVs — shell companies set up to hold private shares and pool outside money around them. Since direct transfers require company approval, SPVs became the standard workaround: the shell buys the shares, you buy into the shell. The problem is layering. PitchBook analyst Emily Zheng described "multiple layers of SPVs that create multiple layers of management fees" — nested structures where each layer charges its own fees and makes it harder to verify whether the underlying shares were ever legitimately acquired. Under Tuesday's statements, if the original transfer into any SPV lacked board approval, the whole chain is void.
The regulated marketplaces are on the list too
Anthropic's blocklist does not stop at gray-market operators. Forge Global and Hiive are on it — two of the most established regulated secondary marketplaces, where accredited investors trade private-company shares. Last month Anthropic's implied valuation on Forge hit roughly $1 trillion, above OpenAI's $880 billion on the same platform — a figure Forge's own CEO confirmed.
That is the part that reshapes the market. The labs drew no line between unregulated schemes and regulated platforms. The question is not whether the venue is legitimate. It is whether the company approved this specific transfer.
The $6.6 billion template
The carve-out both companies are defending is the board-authorized tender. In October 2025, OpenAI ran one: more than 600 current and former employees sold vested shares — capped at $30 million each — to institutional buyers including Thrive Capital, SoftBank, Dragoneer, and T. Rowe Price. OpenAI organized it, disclosed it, and approved every transfer.
A secondary sale where the company controls who buys and signs off on each transfer is legal. The crackdown targets everything that skips that step.
What to ask if you hold any of this
Robinhood Ventures Fund I bought $75 million in OpenAI stock about three weeks ago, offering retail investors exposure through a NYSE-listed closed-end fund. The awkward part: Robinhood's own product page discloses that the fund "obtains exposure either through a direct investment in a company or via one or more special purpose vehicles." Robinhood told Decrypt the fund owns the shares directly with "no SPV or intermediary structure" involved. Take that at face value and the position is clean — but the test both labs just set is narrower than any platform's reassurance: did the company approve this specific transfer in writing?
That is the practical question for anyone holding private AI exposure through a side door, and almost nobody downstream can answer it. The demand making all of this chaotic is easy to understand: Anthropic's annualized revenue ran from $9 billion at the end of 2025 to $30 billion by April 2026, a 233% jump in a single quarter, with Amazon committed to invest up to $25 billion. Investors who cannot get in through official channels will keep looking for side doors. Tuesday was both companies bolting those doors — and Anthropic publishing the list of doors it found ajar.
Sources
- [1] Decrypt — “Anthropic and OpenAI Warn Buyers: Unauthorized AI Startup Shares May Be Worthless” (Oct 9, 2026)Read source